Risk of death twice as high among cancer patients with COVID-19
May 29, 2020
Mays Cancer Center faculty members authored the data analysis involving more than 900 cancer patients.
Cancer drugs cause large cells that resist treatment; scientist aims to stop it
May 28, 2020
Fueled by genetic changes due to cancer therapy itself, rogue cells may become very large with twice or quadruple the number of chromosomes found in healthy cells. Dr. Daruka Mahadevan, of the Mays Cancer Center, seeks to find drugs that prevent or treat this problem.
Cancer drugs cause large cells that resist treatment; scientist aims to stop it
May 28, 2020
A cancer therapy may shrink the tumor of a patient, and the patient may feel better. But unseen on a CT scan or MR image, some of the cells are undergoing ominous changes. Fueled by new genetic changes due to cancer therapy itself, these rogue cells are becoming very large with twice or quadruple the […]
MedicalXpress: Cancer researchers locate drivers of tumor resistance
May 18, 2020
Cancer biologists at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, have identified important drivers that enable tumors to change their behavior and evade anticancer therapies. Read the full story.
Cancer researchers locate drivers of tumor resistance
May 18, 2020
Cancer biologists at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, have identified important drivers that enable tumors to change their behavior and evade anticancer therapies. By studying tumors in cell lines, mice and human samples, the team documented genetic signals that promote the conversion of cancer cells from one stage […]
AAMDS webinar for patients: Understanding the overlap between MDS and MPNs
May 15, 2020
Ruben Mesa, M.D., FACP, was the featured speaker during a webinar for patients sponsored by the Aplastic Anemia & MDS International Foundation. Dr. Mesa discusses the overlap between MDS (myelodysplastic sydromes) and MPNs (myeloproliferative neoplasms), including diagnosis and treatment options and the latest in clinical trials. He also provides an update on the impact of […]